Latest News
BrightFocus Foundation recognizes six scientists studying macular degeneration and glaucoma, awarding research grants named in honor of leaders in vision science.
The world’s largest vision science meeting is about to begin. ARVO 2018 will showcase BrightFocus leadership and the latest advances in macular degeneration and glaucoma research being from achieved by BrightFocus grantees.
BrightFocus Foundation today announced $13.5 million in new scientific research grants seeking cures for Alzheimer’s disease, macular degeneration, and glaucoma.
The spring edition of Alzheimer's Disease Research Review provides information about a major advance in drug development that started with funding from Alzheimer's Disease Research (ADR), explains why clinical trial volunteers are key for curing Alzheimer’s, summarizes recommendations for home-based dementia care that were unveiled at an event sponsored by ADR, offers some tips and advice for informing your loved one about their Alzheimer’s diagnosis, and more.
Two new pressure-lowering glaucoma medications have been approved by the FDA and are becoming available in the United States. Each is unique, and one is the first in a new class of drugs.
Different macular disorders could one day be stopped by treatments aimed at some of the earliest cellular changes that these diseases have in common. Read more about this exciting research, find out why bacteria in our guts can affect our risk of developing age-related macular degeneration (AMD), and learn about a clinical trial that will help determine if alpha lipoic acid can slow down the growth of the advanced form of dry AMD, all in the spring 2018 edition of Macular Degeneration Research News.
The winter 2018 edition of the National Glaucoma Research Report has information on a BrightFocus research grant that is leading to a new understanding of glaucoma, an article outlining the connection between diabetes and glaucoma, helpful facts about how clinical trials work, and much more.
Learn about a major study that sheds new light into the causes of Alzheimer's, an innovative Alzheimer's project that is (literally) out of this world, helpful tips for when Alzheimer's affects sleep, a Q&A on clinical trials with Dr. Mario Cornacchione, and more in the winter edition of the Alzheimer's Disease Research newsletter.